Research Articles and Other Literature

Article
Date Published
Author(s)
Link to Article
Europol Joint Report on a new psychoactive substance: Carfentanil
2017
European Monitoring Centre for Drugs and Drug Addiction
https://www.emcdda.europa.eu/system/files/publications/6502/2017.6256_EN_04-WEB.pdf
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose A Randomized Clinical Trial
2019
Paul Dietze, PhD, Marianne Jauncey, MPH (Hons), Allison Salmon, PhD, Mohammadreza Mohebbi, PhD, Julie Latimer, BN (Hons), Ingrid van Beek, MD, Colette McGrath, MHM, and Debra Kerr, PhD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902775/
Drug Overdose Deaths Involving Fentanyl, 2011–2016
2019
Merianne Rose Spencer, M.P.H., Margaret Warner, Ph.D., and Brigham A. Bastian, B.S., National Center for Health Statistics; James P. Trinidad, M.P.H., M.S., U.S. Food and Drug Administration; and Holly Hedegaard, M.D., M.S.P.H., National Center for Health Statistics
https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_03-508.pdf?fbclid=IwAR1PDY4RTy2eXITF4expj0FLF8Nr8N5A4V_B7RlLiWlaUbsHDG-lz8JiSZU
Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018
2020
Nana Wilson, PhD; Mbabazi Kariisa, PhD; Puja Seth, PhD; Herschel Smith IV, MPH; Nicole L. Davis, PhD
https://www.cdc.gov/mmwr/volumes/69/wr/mm6911a4.htm
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016
2017
Julie K. O’Donnell, PhD, John Halpin, MD, Christine L. Mattson, PhD, Bruce A. Goldberger, PhD, and R. Matthew Gladden, PhD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689219/
Death Rates from Unintentional and Undetermined Prescription Opioid Overdoses and Dispensing Rates of Controlled Prescription Opioid Analgesics - 2011-2015
2017
Scott K Proescholdbell, Mary E Cox, Alex Asbun
https://www.ncmedicaljournal.com/content/ncm/78/2/142.full.pdf
Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016
2017
Nicholas J. Somerville, MD; Julie O’Donnell, PhD; R. Matthew Gladden, PhD; Jon E. Zibbell, PhD; Traci C. Green, PhD; Morgan Younkin, MD; Sarah Ruiz, MSW; Hermik Babakhanlou-Chase, MPH; Miranda Chan, MPH; Barry P. Callis, MSW; Janet Kuramoto-Crawford, PhD; Henry M. Nields, MD, PhD; Alexander Y. Walley, MD
https://www.cdc.gov/mmwr/volumes/66/wr/mm6614a2.htm
Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015
2017
Gery P. Guy Jr., PhD; Kun Zhang, PhD; Michele K. Bohm, MPH; Jan Losby, PhD; Brian Lewis; Randall Young, MA; Louise B. Murphy, PhD; Deborah Dowell, MD
https://www.cdc.gov/mmwr/volumes/66/wr/mm6626a4.htm
Buprenorphine physician supply: Relationship with state-level prescription opioid mortality
2017
Hannah K. Knudsen, Jennifer R. Havens, Michelle R. Lofwall, Jamie L. Studts, Sharon L. Walsh
https://www.sciencedirect.com/science/article/pii/S0376871616310304?via%3Dihub
Buprenorphine Exposures Among Children and Adolescents Reported to US Poison Control Centers
2018
Sara Post, Henry A. Spiller, Marcel J. Casavant, Thitphalak Chounthirath and Gary A. Smith
https://pediatrics.aappublications.org/content/pediatrics/142/1/e20173652.full.pdf
Association of Law Enforcement Seizures of Heroin, Fentanyl, and Carfentanil With Opioid Overdose Deaths in Ohio, 2014-2017
2019
Jon E. Zibbell, PhD, Arnie P. Aldridge, PhD, Dennis Cauchon, Jolene DeFiore-Hyrmer, PhD, MPH, and Kevin P. Conway, PhD
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902770/
An Expanding World of Novel Psychoactive Substances: Opioids
2017
Jolanta B. Zawilska
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492455/
Addressing the Fentanyl Threat to Public Health
2017
Richard G. Frank, Ph.D., and Harold A. Pollack, Ph.D.
https://www.nejm.org/doi/full/10.1056/NEJMp1615145
ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders
2017
Michael J. Moss, Brandon J. Warrick, Lewis S. Nelson, Charles A. McKay, Pierre-André Dubé, Sophie Gosselin, Robert B. Palmer, and Andrew I. Stolbach
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711758/
Opioid Misuse Increases Among Older Adults
2017
SAMHSA
https://www.samhsa.gov/data/sites/default/files/report_3186/Spotlight-3186.pdf
Opioid Overdose Outbreak — West Virginia, August 2016
2017
Joel Massey, MD; Michael Kilkenny, MD; Samantha Batdorf, MPH; Sarah K. Sanders, PhD; Debra Ellison; John Halpin, MD; R. Matthew Gladden, PhD; Danae Bixler, MD; Loretta Haddy, PhD; Rahul Gupta, MD
https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6637a3.pdf
Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study
2020
Mathew V Kiang, Keith Humphreys, Mark R Cullen, Sanjay Bas
https://www.bmj.com/content/368/bmj.l6968
Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected — 28 States and the District of Columbia, July 2016–December 2018
2020
Julie O’Donnell, PhD; R. Matt Gladden, PhD; Bruce A. Goldberger, PhD; Christine L. Mattson, PhD; Mbabazi Kariisa, PhD
https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6910a4-H.pdf
Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016–June 2017
2018
Christine L. Mattson, PhD; Julie O’Donnell, PhD; Mbabazi Kariisa, PhD; Puja Seth, PhD; Lawrence Scholl, PhD; R. Matthew Gladden, PhD
https://www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6734a2-H.pdf
Overdose Deaths Involving Fentanyl and Fentanyl Analogs — New York City, 2000–2017
2019
Cody Colon-Berezin, MSPH; Michelle L. Nolan, MPH; Jaclyn Blachman-Forshay, MPH; Denise Paone, EdD
https://www.cdc.gov/mmwr/volumes/68/wr/pdfs/mm6802a3-H.pdf
Overdose Deaths Related to Fentanyl and Its Analogs — Ohio, January–February 2017
2017
Raminta Daniulaityte, PhD; Matthew P. Juhascik, PhD; Kraig E. Strayer; Ioana E. Sizemore, PhD; Kent E. Harshbarger, MD, JD; Heather M. Antonides; Robert R. Carlson, PhD
https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6634a3.pdf
Notes from the Field: Overdose Deaths with Carfentanil and Other Fentanyl Analogs Detected — 10 States, July 2016–June 2017
2018
Julie O’Donnell, PhD; R. Matthew Gladden, PhD; Christine L. Mattson, PhD; Mbabazi Kariisa, PhD
https://www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6727a4-H.pdf
Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion — United States, 2008–2015
2016
Daniel S. Budnitz, MD; Maribeth C. Lovegrove, MPH; Mathew R.P. Sapiano, PhD; Justin Mathew, PharmD; Scott R. Kegler, PhD; Andrew I. Geller, MD; Christian Hampp, PhD
https://www.cdc.gov/mmwr/volumes/65/wr/pdfs/mm6541a5.pdf
Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013
2016
Janneke Berecki‐Gisolf, Behrooz Hassani‐Mahmooei, Angela Clapperton, Roderick McClure
https://onlinelibrary.wiley.com/doi/full/10.1111/1753-6405.12568
The 2016 Heroin Signature Program Report: DEA Intelligence Report Copy
2018
DEA
https://www.dea.gov/sites/default/files/2018-10/Heroin%20Signature%20Report%20FINAL.pdf
Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000–2015
2017
Jakob D. Allen, Marcel J. Casavant, MD, Henry A. Spiller, MS, D.ABAT, Thiphalak Chounthirath, MS, Nichole L. Hodges, PhD, Gary A. Smith, MD, DrPH
https://pediatrics.aappublications.org/content/pediatrics/139/4/e20163382.full.pdf
Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study
2019
Joel D. Hudgins, John J. Porter, Michael C. Monuteaux, Florence T. Bourgeois
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002922
Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas — United States, 2015–2017
2019
Kumiko M. Lippold, PhD; Christopher M. Jones, PharmD; Emily O’Malley Olsen, PhD; Brett P. Giroir, MD
https://www.cdc.gov/mmwr/volumes/68/wr/mm6843a3.htm
Rapid widespread distribution of intranasal naloxone for overdose prevention
2017
Desiree Madah-Amiri, Thomas Clausen, Philipp Lobmaier
https://www.sciencedirect.com/science/article/pii/S0376871617300315?via%3Dihub
QuickStats: Rates of Drug Overdose Deaths Involving Heroin,* by Selected Age Groups — United States, 2006–2015
2017
National Center for Health Statistics
https://www.cdc.gov/mmwr/volumes/65/wr/pdfs/mm6552a12.pdf
Report on the Risk Assessment of Acryloylfentanyl
2017
European Monitoring Centre for Drugs and Drug Addiction
https://www.emcdda.europa.eu/publications/risk-assessments/acryloylfentanyl_en
Report on the Risk Assessment of Furanylfentanyl
2017
European Monitoring Centre for Drugs and Drug Addiction
https://www.emcdda.europa.eu/publications/risk-assessments/furanylfentanyl_en
Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD
2017
Sarah G. Mars, Ph.D; Jeff Ondocsin, M.A.; Daniel Ciccarone, MD, MPH
https://www.tandfonline.com/doi/abs/10.1080/02791072.2017.1394508?journalCode=ujpd20
State and Substate Estimates of Nonmedical Use of Prescription Pain Relievers
2017
Rachel N. Lipari, Ph.D., Struther L. Van Horn, M.A., Arthur Hughes, M.S. and, Matthew Williams, Ph.D.
https://www.samhsa.gov/data/sites/default/files/report_3187/ShortReport-3187.html
The 2015 Heroin Signature Program Report: DEA Intelligence Report
2017
DEA
https://www.dea.gov/sites/default/files/2018-07/DEA-DCW-DIR-032-17%20The%202015%20Heroin%20Signature%20Report.pdf
The Role of Science in Addressing the Opioid Crisis
2017
Nora D. Volkow, M.D., and Francis S. Collins, M.D., Ph.D.
https://www.nejm.org/doi/full/10.1056/NEJMsr1706626
Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region — United States, 2006–2015
2017
Julie K. O’Donnell, PhD1; R. Matthew Gladden, PhD1; Puja Seth, PhD
https://www.cdc.gov/mmwr/volumes/66/wr/mm6634a2.htm
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses — United States, July 2016–September 2017
2018
Alana M. Vivolo-Kantor, PhD1; Puja Seth, PhD1; R. Matthew Gladden, PhD1; Christine L. Mattson, PhD1; Grant T. Baldwin, PhD1; Aaron Kite-Powell, MS2; Michael A. Coletta, MPH
https://www.cdc.gov/mmwr/volumes/67/wr/mm6709e1.htm
Trends in the Use of Methadone, Buprenorphine, and Extended-Release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (UPDATE)
2017
Cathie E. Alderks, Ph.D.
https://www.samhsa.gov/data/sites/default/files/report_3192/ShortReport-3192.pdf
The Future of Fentanyl and Other Synthetic Opioids
2019
Bryce Pardo, Jirka Taylor, Jonathan P. Caulkins, Beau Kilmer, Peter Reuter, Bradley D. Stein
https://www.rand.org/pubs/research_reports/RR3117.html
Understanding America's Surge in Fentanyl and Other Synthetic Opioids
2019
Bryce Pardo, Jirka Taylor, Jonathan P. Caulkins, Beau Kilmer, Peter Reuter, Bradley D. Stein
https://www.rand.org/pubs/research_briefs/RB10091.html
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
2018
Marc R. Larochelle, MD, MPH, Dana Bernson, MPH, Thomas Land, PhD, Thomas J. Stopka, PhD, MHS, Na Wang, MA, Ziming Xuan, ScD, SM, Sarah M. Bagley, MD, MSc, Jane M. Liebschutz, MD, MPH, Alexander Y. Walley, MD, MSc
https://www.acpjournals.org/doi/abs/10.7326/M17-3107
Unintentional Fentanyl Overdoses Among Persons Who Thought Ther Were Snorting Cocaine - Fresno, CA - January 7, 2019
2019
Patil Armenian, MD; Jeffrey D. Whitman, MD; Adina Badea, PhD; Whitney Johnson, MD; Chelsea Drake, MS; Simranjit Singh Dhillon; Michelle Rivera; Nicklaus Brandehoff, MD; Kara L. Lynch, PhD
https://pdfs.semanticscholar.org/3fd8/1b0d931ec80cff7de1923a33ad6b956683b1.pdf
Risk Factors for Opioid-Use Disorder and Overdose
2017
Lynn R. Webster
https://www.ingentaconnect.com/content/wk/ane/2017/00000125/00000005/art00041
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder
2017
C. Holly A. Andrilla, Cynthia Coulthard and Eric H. Larson
https://www.annfammed.org/content/15/4/359.short
Medication-Assisted Treatment of Opioid Use Disorder. Review of the Evidence and Future Directions
2015
Connery, Hilary Smith MD, PhD
https://journals.lww.com/hrpjournal/FullText/2015/03000/Medication_Assisted_Treatment_of_Opioid_Use.2.aspx
Confronting the Stigma of Opioid Use Disorder—and Its Treatment
2014
Yngvild Olsen, MD, MPH; Joshua M. Sharfstein, MD
https://jamanetwork.com/journals/jama/article-abstract/1838170
The Impact of Substance Use Disorders on Families and Children: From Theory to Practice
2013
Laura Lander, Janie Howsare, and Marilyn Byrne
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725219/
Page 1 of 1